Astronics (AC1) Q2 2026 Earnings Report

The call conveyed strong operational and financial momentum — record revenue, bookings, backlog and materially improved margins (adjusted EBITDA ~19.8%), supported by major program wins (MV-75 development and a $44.7M Army production order), improving cash generation and a healthier balance sheet. Headwinds exist (ongoing tariff costs, temporary margin pressure in Test Systems during ramp, GEO disruption from LEO transition, and remaining contract repricing work), but management presented clear levers (volume, pricing, efficiency, portfolio simplification) with room to run. On balance, the positives substantially outweigh the negatives.

Management raised FY2026 revenue guidance to $1.02–$1.04 billion and expects Q3 sales of $265–$275 million with Q4 revenue modestly higher, targeting adjusted operating/EBITDA margins in the high teens (Q2 adjusted EBITDA margin = 19.8%, adjusted operating margin = 16.6%); they forecast ~$35 million of 2026 revenue from the MV‑75 FLRAA program, expect the $44.7M Army 4549 radio test production award to ramp to full‑rate by the end of Q4 (supporting ~18 months of deliveries) and to drive Test margins closer to Aerospace levels, and noted Q2 bookings of $306M with Aerospace bookings $243.1M (book‑to‑bill 1.02) and Test bookings $63.1M (book‑to‑bill 2.78) leaving backlogs of $657.2M (Aerospace) and $123.3M (Test); other guidance items include R&D of roughly $10–$12M per quarter, full‑year CapEx of $40–$45M (YTD $16.9M), expected future IEEPA tariff refunds of ~$6–$8M (timing uncertain) offset by an ongoing tariff run‑rate of ~$3–$4M/quarter, an expectation to be free‑cash‑flow positive for the remainder of the year, available liquidity of $253.2M and long‑term debt of $310.3M, and potential additional deferred tax valuation allowance release of roughly $40–$50M pending sufficient future taxable income.